Loading
Loading
Source Filing
Executive Record
Reported Pay
Compensation pending.
Findings
Reviewing FY2024 executive compensation against shareholder return and the latest filing-backed pay disclosures.
Spread between reported pay and stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for BRKR.
Team view
5 executives
Executive Officer
Total PayFY2024
$5.5M
Bruker NANO Group
Total PayFY2024
$2.6M
Financial Officer
Total PayFY2024
$2.3M
Bruker CALID Group
Total PayFY2024
$1.5M
Bruker Bio Spin Group
Total PayFY2024
$1.5M
Ask a question about this filing
01FY2024 total compensation breakdown
Activity timeline · FY2024
Recent events from filings
A pay-performance summary will appear here once the verdict loads above.
02Pay changes vs. stock performance
1 year of data
Peer context
Dashed line marks the mid-cap median compensation benchmark for companies around $6.0B market cap, based on 159 peers in this size band.
03Recent insider trades by officers and directors
~32 trades
04Board composition and compensation for FY2026
This company is expected to file its proxy statement soon.
05Take action on executive compensation
Shareholder activism tools
Start or join campaigns to engage with BRKR's board on executive compensation, governance, and shareholder proposals.
Activism Beta — Sign in to start or join campaigns
06For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2024 | Frank H. Laukien Executive Officer | $0.97M | $1.19M | $1.76M | $1.58M | $0.04M | $5.53M |
| 2024 | Mark R. Munch Bruker NANO Group | $0.73M | $0.65M | $0.93M | $0.31M | $0.03M | $2.64M |
| 2024 | Gerald N. Herman Financial Officer | $0.64M | $0.39M | $0.94M | $0.31M | $0.02M | $2.29M |
| 2024 | Juergen W. Srega Bruker CALID Group | $0.48M | $0.20M | $0.56M | $0.19M | $0.09M | $1.52M |
| 2024 | Falko Busse Bruker Bio Spin Group | $0.50M | $0.33M | $0.37M | $0.12M | $0.14M | $1.47M |
| 2023 | Frank H. Laukien Executive Officer | $0.93M | $1.57M | $2.56M | $0.77M | $0.03M | $5.86M |
| 2023 | Mark R. Munch Bruker NANO Group | $0.69M | $0.91M | $0.82M | $0.27M | $0.03M | $2.73M |
| 2023 | Gerald N. Herman Financial Officer | $0.60M | $0.51M | $0.81M | $0.27M | $0.02M | $2.20M |
| 2023 | Juergen W. Srega Bruker CALID Group | $0.45M | $0.30M | $0.47M | $0.16M | $0.09M | $1.47M |
| 2023 | Falko Busse Bruker Bio Spin Group | $0.47M | $0.34M | $0.30M | $0.10M | $0.13M | $1.35M |
| 2022 | Frank H. Laukien Executive Officer | $0.87M | $0.91M | $2.48M | $0.76M | $0.04M | $5.06M |
| 2022 | Mark R. Munch Bruker NANO Group | $0.65M | $0.76M | $0.79M | $0.27M | $0.03M | $2.50M |
| 2022 | Gerald N. Herman Financial Officer | $0.57M | $0.27M | $0.78M | $0.26M | $0.02M | $1.90M |
| 2022 | Juergen W. Srega Bruker CALID Group | $0.41M | $0.14M | $0.47M | $0.16M | $0.09M | $1.28M |
| 2022 | Juergen Srega Bruker CALID Group | $0.41M | $0.14M | $0.47M | $0.16M | $0.09M | $1.28M |
| 2022 | Falko Busse Bruker Bio Spin Group | $0.43M | $0.22M | $0.29M | $0.10M | $0.12M | $1.15M |
| 2021 | Frank H. Laukien Executive Officer | $0.81M | $1.62M | $2.41M | $0.75M | $0.01M | $5.59M |
| 2021 | Mark R. Munch Bruker NANO Group | $0.62M | $0.91M | $0.77M | $0.27M | $0.02M | $2.58M |
| 2021 | Gerald N. Herman Financial Officer | $0.55M | $0.52M | $0.64M | $0.23M | $0.01M | $1.94M |
| 2021 | Juergen Srega Bruker CALID Group | $0.44M | $0.42M | $0.47M | $0.17M | $0.10M | $1.60M |
| 2021 | Falko Busse Bruker Bio Spin Group | $0.42M | $0.21M | $0.27M | $0.10M | $0.11M | $1.10M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.